modernas phase 1 and 2 human clinical trials Search Results


heterologous booster dose  (Moderna)
86
Moderna heterologous booster dose
Heterologous Booster Dose, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/additional+booster+dose+moderna+spikevax/10__53730_slash_ijhs__v6n1__3626-117-15-33
Average 86 stars, based on 1 article reviews
heterologous booster dose - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
naked mrnas  (AstraZeneca ltd)
90
AstraZeneca ltd naked mrnas
Naked Mrnas, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/naked+mrnas/pmc11340501-110-29-43
Average 90 stars, based on 1 article reviews
naked mrnas - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human recombinant pth 1–34  (Bachem)
90
Bachem human recombinant pth 1–34
Human Recombinant Pth 1–34, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/human+pth++1+34+/pm40345077-43-37-44
Average 90 stars, based on 1 article reviews
human recombinant pth 1–34 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mrna 1010 influenza  (Moderna)
86
Moderna mrna 1010 influenza
Mrna 1010 Influenza, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/1010+mrna/pmc13029830-342-25-0
Average 86 stars, based on 1 article reviews
mrna 1010 influenza - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
mrna 1273 sars cov 2 vaccines  (Moderna)
86
Moderna mrna 1273 sars cov 2 vaccines
Epidemiological situation of COVID-19 and influenza from 2020. ( A ) Epidemiological situation of COVID-19 and influenza in the world, adapted from World Health Organization (WHO) 2025, <t>Influenza</t> <t>and</t> <t>SARS-CoV-2</t> virus detections reported to FluNet ; ( B ) Circulation of influenza and SARS-CoV-2 viruses in Russia based on data from the A.A. Smorodintsev Influenza Research Institute. Modified from .
Mrna 1273 Sars Cov 2 Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/1273+mrna+%D0%B8%D0%BB%D0%B8/pmc13029830-342-28-0
Average 86 stars, based on 1 article reviews
mrna 1273 sars cov 2 vaccines - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
mrna 1073  (Moderna)
86
Moderna mrna 1073
Epidemiological situation of COVID-19 and influenza from 2020. ( A ) Epidemiological situation of COVID-19 and influenza in the world, adapted from World Health Organization (WHO) 2025, <t>Influenza</t> <t>and</t> <t>SARS-CoV-2</t> virus detections reported to FluNet ; ( B ) Circulation of influenza and SARS-CoV-2 viruses in Russia based on data from the A.A. Smorodintsev Influenza Research Institute. Modified from .
Mrna 1073, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/1073+mrna/pmc13029830-342-16-0
Average 86 stars, based on 1 article reviews
mrna 1073 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
recombinant human trail (dulanermin)  (Genentech inc)
90
Genentech inc recombinant human trail (dulanermin)
Epidemiological situation of COVID-19 and influenza from 2020. ( A ) Epidemiological situation of COVID-19 and influenza in the world, adapted from World Health Organization (WHO) 2025, <t>Influenza</t> <t>and</t> <t>SARS-CoV-2</t> virus detections reported to FluNet ; ( B ) Circulation of influenza and SARS-CoV-2 viruses in Russia based on data from the A.A. Smorodintsev Influenza Research Institute. Modified from .
Recombinant Human Trail (Dulanermin), supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modernas+phase+1+and+2+human+clinical+trials/apo2l+trail/pmc05738353-158-4-8
Average 90 stars, based on 1 article reviews
recombinant human trail (dulanermin) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Epidemiological situation of COVID-19 and influenza from 2020. ( A ) Epidemiological situation of COVID-19 and influenza in the world, adapted from World Health Organization (WHO) 2025, Influenza and SARS-CoV-2 virus detections reported to FluNet ; ( B ) Circulation of influenza and SARS-CoV-2 viruses in Russia based on data from the A.A. Smorodintsev Influenza Research Institute. Modified from .

Journal: Vaccines

Article Title: SARS-CoV-2 and Influenza Co-Circulation and Co-Vaccination: A Narrative Review

doi: 10.3390/vaccines14030283

Figure Lengend Snippet: Epidemiological situation of COVID-19 and influenza from 2020. ( A ) Epidemiological situation of COVID-19 and influenza in the world, adapted from World Health Organization (WHO) 2025, Influenza and SARS-CoV-2 virus detections reported to FluNet ; ( B ) Circulation of influenza and SARS-CoV-2 viruses in Russia based on data from the A.A. Smorodintsev Influenza Research Institute. Modified from .

Article Snippet: Moderna successfully conducted Phase 1 and 2 trials to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1073 (SARS-CoV-2 and Influenza Vaccine) when compared to co-administered mRNA-1010 (Influenza) and mRNA-1273 (SARS-CoV-2) vaccines and to mRNA-1010 and mRNA-1273 vaccines in healthy adults 18–75 years [ ].

Techniques: Virus, Modification